Tuesday, April 5, 2016 5:02:00 AM PDT | VentureDeal
New York, New York -- Bioanalytics technology company Celmatix has secured $4.8 million in new equity venture capital, according to an SEC regulatory filing.
Celmatix says that it "uses big data analytics and genomics to improve fertility treatments and pave the way for proactive fertility management." Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds. One investor made the investment, according to the filing. CEO Piraye Beim co-founded the company in 2009.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
